New Issue!
The Latest
Ebola vaccine for Bundibugyo strain could take months before human trials
What to know about the Ebola outbreak
11 TV Hill: Johns Hopkins Medicine expert answers questions about hantavirus
How the bacteria in your gut could raise colon cancer risk
At last, a pill that can prevent COVID after exposure to infected people
Johns Hopkins Medicine doctor shares Hantavirus concerns with 2 Marylanders being monitored
6 tick-borne diseases that should be on your radar
Are Cruises Still Safe After Deadly Hantavirus Outbreak? What To Know
Scientists pinpoint how toxic bacteria in the gut causes colon cancer - as disease surges in under 50s
What Travelers Should Know About the Hantavirus Outbreak on a Cruise Ship
Syphilis making a comeback, health officials warn. CDC map shows where risk is highest
Q&A: Diagnosing & Treating Co- and Superinfections in Viral Pneumonia
A common stomach bug has become harder to treat
Partnering With Methadone Clinics “Transforms” Hep C Care, Study Finds
2026-04-23 | Filter Magazine | Seun Falade-Nwulia
Tuberculosis vaccine shows promise as once-fatal disease evades treatment
Red Blood Cell Transfusion Benefits Patients With Babesiosis
On-Site Hepatitis C Care Boosts Treatment Uptake
Johns Hopkins Team Develops Therapeutic, Nasally-Delivered DNA Vaccine for Tuberculosis
A New, Highly Mutated COVID Variant Called 'Cicada' Is Spreading in the US. Know These Symptoms
news releases & original stories Hopkins Headliners
-
Most cases of HIV persistence in blood following treatment explained by defective copies of the virus
2026-06-08 | Johns Hopkins Medicine News Release | Francesco Simonetti
-
Solving a 15 Year Mystery Scientists Discover How Gut Bacteria Toxin Invades Colon Cells to Trigger Cancer
2026-05-07 | Johns Hopkins Medicine News Release | Cynthia Sears
-
Hopkins Infectious Disease Expert on Why Science Diplomacy Matters Today
2026-04-29 | Johns Hopkins University Bloomberg Center | Amita Gupta
-
10 Insights from the 2026 Science Diplomacy Summit
2026-04-22 | Johns Hopkins University Bloomberg Center | Amita Gupta
-
Johns Hopkins Team Develops Therapeutic, Nasally Delivered DNA Vaccine for Tuberculosis
Research shows the vaccine — in combination with drug therapy — accelerated a relapse-free TB cure in mice, improved activity of a drug-resistant TB regimen and stimulated immune responses in nonhuman primates
-
Screening And Preventive Treatment Program Reduced Tuberculosis Incidence 83% Among Tibetan Children Living in Northern India
Study conducted partially with federal funds shows a comprehensive effort can achieve rapid and sustained reduction of disease transmission and impact in high TB burden areas using existing control measures
-
Five Johns Hopkins Medicine Researchers Named Fellows of the American Association for the Advancement of Science
Dr. Noreen Hynes is among the 2025 class of fellows.
-
Johns Hopkins Medicine-led consortium receives $24 million federal grant to find hepatitis B cure
The Johns Hopkins Medicine-led, multinational Hepatitis B and HIV Cure Consortium was recently established through the awarding of a five-year, $24 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID).
-
One Versus Three: Federally Funded Clinical Trial Shows Daily Meds for a Month Comparable to Once Weekly for Three Months to Treat TB
Clinical trial shows a 1-month regimen to treat latent tuberculosis infection is noninferior to 3-month course
-
Federally Funded Clinical Trial Suggests Knowing HIV ‘Viral Load’ Doesn’t Improve Number of Patients Seeking Needed Care
A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the number of patients seeking treatment for active HIV infection or preventive care if uninfected, but at high risk of becoming infected.
